These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9869961)

  • 1. Pacing threshold increase in nonthoracotomy implantable defibrillator leads: implications for battery longevity and margin of safety.
    Epstein AE; Plumb VJ; Kirk KA; Kay GN
    J Interv Card Electrophysiol; 1997 Sep; 1(2):131-4. PubMed ID: 9869961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of the effect of biphasic waveform defibrillation on ventricular pacing thresholds.
    Kudenchuk PJ; Poole JE; Dolack GL; Gleva MJ; Anderson J; Troutman C; Bardy GH
    J Cardiovasc Electrophysiol; 1997 May; 8(5):485-95. PubMed ID: 9160224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination biphasic waveform plus sequential pulse defibrillation improves defibrillation efficacy of a nonthoracotomy lead system.
    Exner D; Yee R; Jones DL; Klein GJ; Mehra R
    J Am Coll Cardiol; 1994 Feb; 23(2):317-22. PubMed ID: 8294680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pacing and sensing optimization of permanent His-bundle pacing in cardiac resynchronization therapy/implantable cardioverter defibrillators patients: value of integrated bipolar configuration.
    Su L; Xu L; Wu SJ; Huang WJ
    Europace; 2016 Sep; 18(9):1399-405. PubMed ID: 26581403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
    J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Implantable defibrillator using epicardial and endocardial leads. Results of 36 implantations].
    Sadoul N; Poujois JN; Pinelli G; Villemot JP; de Chillou C; Kanj H; Reeb T; Dodinot B; Aliot E
    Arch Mal Coeur Vaiss; 1993 Nov; 86(11):1567-72. PubMed ID: 8010856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apical versus Non-Apical Lead: Is ICD Lead Position Important for Successful Defibrillation?
    Amit G; Wang J; Connolly SJ; Glikson M; Hohnloser S; Wright DJ; Brachmann J; Defaye P; Neuzner J; Mabo P; Vanerven L; Vinolas X; O'Hara G; Kautzner J; Appl U; Gadler F; Stein K; Konstantino Y; Healey JS
    J Cardiovasc Electrophysiol; 2016 May; 27(5):581-6. PubMed ID: 26888558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A second defibrillator chest patch electrode will increase implantation rates for nonthoracotomy defibrillators.
    Solomon AJ; Swartz JF; Rodak DJ; Moore HJ; Hannan RL; Tracy CM; Fletcher RD
    Pacing Clin Electrophysiol; 1996 Sep; 19(9):1304-10. PubMed ID: 9005417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of right ventricular non-apical defibrillator lead position with traditional right ventricular apical position: a single centre experience.
    Kaye GC; Eng LK; Hunt BJ; Dauber KM; Hill J; Gould PA
    Heart Lung Circ; 2015 Feb; 24(2):179-84. PubMed ID: 25224461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First experience with a new nonthoracotomy defibrillation lead system.
    Trappe HJ; Pfitzner P; Wenzlaff P; Fain E; Fieguth HG
    Am Heart J; 1996 Sep; 132(3):599-607. PubMed ID: 8800031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with a new cardioverter defibrillator capable of biphasic waveform pulse and enhanced data storage: results of a prospective multicenter study. European Ventak P2 Investigator Group.
    Neuzner J
    Pacing Clin Electrophysiol; 1994 Jul; 17(7):1243-55. PubMed ID: 7937230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators.
    Stevens SK; Haffajee CI; Naccarelli GV; Schwartz KM; Luceri RM; Packer DL; Rubin AM; Kowey PR
    J Am Coll Cardiol; 1996 Aug; 28(2):418-22. PubMed ID: 8800119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators.
    Link MS; Wang PJ; Haugh CJ; Homoud MK; Foote CB; Costeas XB; Estes NA
    J Interv Card Electrophysiol; 1997 Feb; 1(1):41-8. PubMed ID: 9869950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic rise in defibrillation threshold with a hybrid lead system.
    Tummala RV; Riggio DR; Peters RW; Shorofsky SR; Gold MR
    Am J Cardiol; 1996 Aug; 78(3):309-12. PubMed ID: 8759810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of pacing capture in implantable defibrillators: benefit of evoked response detection using RV coil to can vector.
    Splett V; Trusty JM; Hayes DL; Friedman PA
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 1):1645-50. PubMed ID: 11138302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.